Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.

Revenue
+0.55%
EPS
−85.0%
Free cash flow
+154.2%
Total debt
−4.96%

Quarter to September 2026, against a year earlier

30.43 0.08 −0.26%
Market cap
$29.8B
P/E
25.8×
Fwd P/E
11.2×
Dividend yield
3.33%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100

Koninklijke Philips N.V. (PHG) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a EV/EBITDA of 11.1×. Over the past ten years it has ranged from 3.6× (November 2022) to 40.7× (May 2024); the current reading is higher than 55% of that period. That is in line with the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 10.5× (40.38%)
FY2024 17.6× (48.75%)
FY2023 34.3× 352.33%
FY2022 7.6× (3.32%)
FY2021 7.9× (11.74%)
FY2020 8.9× 0.60%
FY2019 8.8× 27.14%
FY2018 7.0× (48.00%)
FY2017 13.4× 72.45%
FY2016 7.8× (22.42%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 9.2× 0.38%
Jun 2026 9.2× (10.44%)
Mar 2026 10.3× (2.23%)
Dec 2025 10.5× (5.98%)
37 more quarters

Against its own ten years

Low 3.6× High 40.7×
Ten-year median 10.3×
Current reading's percentile 55

EV/EBITDA against peers

Company EV/EBITDA
GKOS Glaukos Corporation compare n/m
SNN Smith & Nephew SNATS, Inc. compare 6.5×
PHG Koninklijke Philips N.V. 11.1×
ZBH Zimmer Biomet Holdings, Inc. compare 12.1×
GEHC GE HealthCare Technologies Inc. compare 13.2×
BSX Boston Scientific Corporation compare 14.0×
STE STERIS plc compare 15.7×
DXCM DexCom, Inc. compare 21.2×
EW Edwards Lifesciences Corporation compare 34.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on PHG